Copyright Reports & Markets. All rights reserved.

Global Protein Drugs Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Protein Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Antibody Drugs
    • 1.2.3 Peptide Hormones
    • 1.2.4 Blood Products
    • 1.2.5 Enzymes
  • 1.3 Market by Application
    • 1.3.1 Global Protein Drugs Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Protein Drugs Market Perspective (2016-2027)
  • 2.2 Protein Drugs Growth Trends by Regions
    • 2.2.1 Protein Drugs Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Protein Drugs Historic Market Share by Regions (2016-2021)
    • 2.2.3 Protein Drugs Forecasted Market Size by Regions (2022-2027)
  • 2.3 Protein Drugs Industry Dynamic
    • 2.3.1 Protein Drugs Market Trends
    • 2.3.2 Protein Drugs Market Drivers
    • 2.3.3 Protein Drugs Market Challenges
    • 2.3.4 Protein Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Protein Drugs Players by Revenue
    • 3.1.1 Global Top Protein Drugs Players by Revenue (2016-2021)
    • 3.1.2 Global Protein Drugs Revenue Market Share by Players (2016-2021)
  • 3.2 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Protein Drugs Revenue
  • 3.4 Global Protein Drugs Market Concentration Ratio
    • 3.4.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2020
  • 3.5 Protein Drugs Key Players Head office and Area Served
  • 3.6 Key Players Protein Drugs Product Solution and Service
  • 3.7 Date of Enter into Protein Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Protein Drugs Breakdown Data by Type

  • 4.1 Global Protein Drugs Historic Market Size by Type (2016-2021)
  • 4.2 Global Protein Drugs Forecasted Market Size by Type (2022-2027)

5 Protein Drugs Breakdown Data by Application

  • 5.1 Global Protein Drugs Historic Market Size by Application (2016-2021)
  • 5.2 Global Protein Drugs Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Protein Drugs Market Size (2016-2027)
  • 6.2 North America Protein Drugs Market Size by Type
    • 6.2.1 North America Protein Drugs Market Size by Type (2016-2021)
    • 6.2.2 North America Protein Drugs Market Size by Type (2022-2027)
    • 6.2.3 North America Protein Drugs Market Size by Type (2016-2027)
  • 6.3 North America Protein Drugs Market Size by Application
    • 6.3.1 North America Protein Drugs Market Size by Application (2016-2021)
    • 6.3.2 North America Protein Drugs Market Size by Application (2022-2027)
    • 6.3.3 North America Protein Drugs Market Size by Application (2016-2027)
  • 6.4 North America Protein Drugs Market Size by Country
    • 6.4.1 North America Protein Drugs Market Size by Country (2016-2021)
    • 6.4.2 North America Protein Drugs Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Protein Drugs Market Size (2016-2027)
  • 7.2 Europe Protein Drugs Market Size by Type
    • 7.2.1 Europe Protein Drugs Market Size by Type (2016-2021)
    • 7.2.2 Europe Protein Drugs Market Size by Type (2022-2027)
    • 7.2.3 Europe Protein Drugs Market Size by Type (2016-2027)
  • 7.3 Europe Protein Drugs Market Size by Application
    • 7.3.1 Europe Protein Drugs Market Size by Application (2016-2021)
    • 7.3.2 Europe Protein Drugs Market Size by Application (2022-2027)
    • 7.3.3 Europe Protein Drugs Market Size by Application (2016-2027)
  • 7.4 Europe Protein Drugs Market Size by Country
    • 7.4.1 Europe Protein Drugs Market Size by Country (2016-2021)
    • 7.4.2 Europe Protein Drugs Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Protein Drugs Market Size (2016-2027)
  • 8.2 Asia-Pacific Protein Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Protein Drugs Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Protein Drugs Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Protein Drugs Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Protein Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Protein Drugs Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Protein Drugs Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Protein Drugs Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Protein Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Protein Drugs Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Protein Drugs Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Protein Drugs Market Size (2016-2027)
  • 9.2 Latin America Protein Drugs Market Size by Type
    • 9.2.1 Latin America Protein Drugs Market Size by Type (2016-2021)
    • 9.2.2 Latin America Protein Drugs Market Size by Type (2022-2027)
    • 9.2.3 Latin America Protein Drugs Market Size by Type (2016-2027)
  • 9.3 Latin America Protein Drugs Market Size by Application
    • 9.3.1 Latin America Protein Drugs Market Size by Application (2016-2021)
    • 9.3.2 Latin America Protein Drugs Market Size by Application (2022-2027)
    • 9.3.3 Latin America Protein Drugs Market Size by Application (2016-2027)
  • 9.4 Latin America Protein Drugs Market Size by Country
    • 9.4.1 Latin America Protein Drugs Market Size by Country (2016-2021)
    • 9.4.2 Latin America Protein Drugs Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Protein Drugs Market Size (2016-2027)
  • 10.2 Middle East & Africa Protein Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Protein Drugs Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Protein Drugs Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Protein Drugs Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Protein Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Protein Drugs Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Protein Drugs Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Protein Drugs Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Protein Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Protein Drugs Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Protein Drugs Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Eli Lilly
    • 11.1.1 Eli Lilly Company Details
    • 11.1.2 Eli Lilly Business Overview
    • 11.1.3 Eli Lilly Protein Drugs Introduction
    • 11.1.4 Eli Lilly Revenue in Protein Drugs Business (2016-2021)
    • 11.1.5 Eli Lilly Recent Development
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Protein Drugs Introduction
    • 11.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2016-2021)
    • 11.2.5 Abbott Laboratories Recent Development
  • 11.3 UCB Group
    • 11.3.1 UCB Group Company Details
    • 11.3.2 UCB Group Business Overview
    • 11.3.3 UCB Group Protein Drugs Introduction
    • 11.3.4 UCB Group Revenue in Protein Drugs Business (2016-2021)
    • 11.3.5 UCB Group Recent Development
  • 11.4 Schering-Plough Corporation
    • 11.4.1 Schering-Plough Corporation Company Details
    • 11.4.2 Schering-Plough Corporation Business Overview
    • 11.4.3 Schering-Plough Corporation Protein Drugs Introduction
    • 11.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2016-2021)
    • 11.4.5 Schering-Plough Corporation Recent Development
  • 11.5 Genentech
    • 11.5.1 Genentech Company Details
    • 11.5.2 Genentech Business Overview
    • 11.5.3 Genentech Protein Drugs Introduction
    • 11.5.4 Genentech Revenue in Protein Drugs Business (2016-2021)
    • 11.5.5 Genentech Recent Development
  • 11.6 Johnson＆Johnson
    • 11.6.1 Johnson＆Johnson Company Details
    • 11.6.2 Johnson＆Johnson Business Overview
    • 11.6.3 Johnson＆Johnson Protein Drugs Introduction
    • 11.6.4 Johnson＆Johnson Revenue in Protein Drugs Business (2016-2021)
    • 11.6.5 Johnson＆Johnson Recent Development
  • 11.7 Bristol-Myers Squibb
    • 11.7.1 Bristol-Myers Squibb Company Details
    • 11.7.2 Bristol-Myers Squibb Business Overview
    • 11.7.3 Bristol-Myers Squibb Protein Drugs Introduction
    • 11.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2016-2021)
    • 11.7.5 Bristol-Myers Squibb Recent Development
  • 11.8 Novo Nordisk
    • 11.8.1 Novo Nordisk Company Details
    • 11.8.2 Novo Nordisk Business Overview
    • 11.8.3 Novo Nordisk Protein Drugs Introduction
    • 11.8.4 Novo Nordisk Revenue in Protein Drugs Business (2016-2021)
    • 11.8.5 Novo Nordisk Recent Development
  • 11.9 Biogen Idec
    • 11.9.1 Biogen Idec Company Details
    • 11.9.2 Biogen Idec Business Overview
    • 11.9.3 Biogen Idec Protein Drugs Introduction
    • 11.9.4 Biogen Idec Revenue in Protein Drugs Business (2016-2021)
    • 11.9.5 Biogen Idec Recent Development
  • 11.10 Dendreon Corporation
    • 11.10.1 Dendreon Corporation Company Details
    • 11.10.2 Dendreon Corporation Business Overview
    • 11.10.3 Dendreon Corporation Protein Drugs Introduction
    • 11.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2016-2021)
    • 11.10.5 Dendreon Corporation Recent Development
  • 11.11 Amgen Inc.
    • 11.11.1 Amgen Inc. Company Details
    • 11.11.2 Amgen Inc. Business Overview
    • 11.11.3 Amgen Inc. Protein Drugs Introduction
    • 11.11.4 Amgen Inc. Revenue in Protein Drugs Business (2016-2021)
    • 11.11.5 Amgen Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Protein Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Protein Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Antibody Drugs
    Peptide Hormones
    Blood Products
    Enzymes

    Segment by Application
    Hospitals
    Clinics
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Eli Lilly
    Abbott Laboratories
    UCB Group
    Schering-Plough Corporation
    Genentech
    Johnson＆Johnson
    Bristol-Myers Squibb
    Novo Nordisk
    Biogen Idec
    Schering-Plough Corporation

    Buy now